ampio lawsuit, ampe lawsuit

Class Action News

Levi & Korsinsky Announces AMPE Lawsuit, Ampio Class Action Commenced

Levi & Korsinsky

September 7, 2018

NEW YORK, September 7, 2018 – Levi & Korsinsky, LLP announces a class action on behalf of shareholders of Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) who purchased shares between December 14, 2017 and August 7, 2018. The Ampio lawsuit alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) the FDA would find Ampio’s AP-003-C Phase 3 clinical trial inadequate and not well-controlled; (2) as a result, Ampio had not successfully completed two pivotal clinical trials for Ampio; (3) consequently, Defendants’ public statements were materially false and misleading at all relevant times. To get more information about the AMPE lawsuit go to: http://www.zlk.com/pslra-1/ampio-pharmaceuticals-inc-loss-form or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

If you suffered a loss in Ampio you have until October 24, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com